This drug has the ability to influence different routes of tumor induction mediated by metabolic stresses (ISR), ATF3 expression, and CHOP, which regulates apoptosis of HNSCC cells [6, 8]. Here, DDIT3 is linked to head and neck squamous cell carcinoma.